About Provention Bio, Inc.
Provention Bio, Inc. (Nasdaq: PRVB) is a pre-commercial stage biopharmaceutical company that is focused on the prevention or interception of immune-mediated disease. Provention’s mission is to develop and commercialize therapeutic candidates targeting the high morbidity, mortality and escalating costs of autoimmune and inflammatory diseases including type 1 diabetes (T1D), celiac disease and lupus. Provention is a virtual company with most employees residing in NJ, MD, CA, and MA. Provention takes pride in its culture and is looking for candidates that will embrace the opportunity with passion and professionalism.